These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30810397)

  • 1. Liquid chromatography coupled to mass spectrometry for metabolite profiling in the field of drug discovery.
    Saurina J; Sentellas S
    Expert Opin Drug Discov; 2019 May; 14(5):469-483. PubMed ID: 30810397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
    Liu ZY
    J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technologies and strategies to characterize and quantitate metabolites in drug discovery and development.
    Ravindran S; Jadhav A; Surve P; Lonsane G; Honrao P; Nanda B
    Biomed Chromatogr; 2014 Nov; 28(11):1547-53. PubMed ID: 25175001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for metabolite profiling based on liquid chromatography.
    Saurina J; Sentellas S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():103-111. PubMed ID: 28088042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent development in liquid chromatography/mass spectrometry and emerging technologies for metabolite identification.
    Liang Y; Wang G; Xie L; Sheng L
    Curr Drug Metab; 2011 May; 12(4):329-44. PubMed ID: 21395529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current developments in LC-MS for pharmaceutical analysis.
    Beccaria M; Cabooter D
    Analyst; 2020 Feb; 145(4):1129-1157. PubMed ID: 31971527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging and spatially resolved quantification of drug distribution in tissues by mass spectrometry.
    Prideaux B; Lenaerts A; Dartois V
    Curr Opin Chem Biol; 2018 Jun; 44():93-100. PubMed ID: 29957376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution chromatography/time-of-flight MSE with in silico data mining is an information-rich approach to reactive metabolite screening.
    Barbara JE; Castro-Perez JM
    Rapid Commun Mass Spectrom; 2011 Oct; 25(20):3029-40. PubMed ID: 21953957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to early in vitro identification of metabolites of new chemical entities in drug discovery and development.
    Baranczewski P; Stańczak A; Kautiainen A; Sandin P; Edlund PO
    Pharmacol Rep; 2006; 58(3):341-52. PubMed ID: 16845208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
    Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
    J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolite characterization in drug discovery utilizing robotic liquid-handling, quadruple time-of-flight mass spectrometry and in-silico prediction.
    Nassar AE; Adams PE
    Curr Drug Metab; 2003 Aug; 4(4):259-71. PubMed ID: 12871044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel approach to performing metabolite identification in drug metabolism.
    Nassar AE; Lee DY
    J Chromatogr Sci; 2007 Mar; 45(3):113-9. PubMed ID: 17462124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of mass spectrometry for metabolite identification.
    Ma S; Chowdhury SK; Alton KB
    Curr Drug Metab; 2006 Jun; 7(5):503-23. PubMed ID: 16787159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass directed peak selection, an efficient method of drug metabolite identification using directly coupled liquid chromatography-mass spectrometry-nuclear magnetic resonance spectroscopy.
    Dear GJ; Plumb RS; Sweatman BC; Ayrton J; Lindon JC; Nicholson JK; Ismail IM
    J Chromatogr B Biomed Sci Appl; 2000 Oct; 748(1):281-93. PubMed ID: 11092605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic approach to development of analytical scale and microflow-based liquid chromatography coupled to mass spectrometry metabolomics methods to support drug discovery and development.
    Geller S; Lieberman H; Kloss A; Ivanov AR
    J Chromatogr A; 2021 Apr; 1642():462047. PubMed ID: 33744605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of relative MS response factors of drug metabolites for semi-quantitative assessment of chemical liabilities in drug discovery.
    Blanz J; Williams G; Dayer J; Délémonté T; Gertsch W; Ramstein P; Aichholz R; Trunzer M; Pearson D
    J Mass Spectrom; 2017 Apr; 52(4):210-217. PubMed ID: 28152561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of triple quadrupole, hybrid linear ion trap triple quadrupole, time-of-flight and LTQ-Orbitrap mass spectrometers in drug discovery phase metabolite screening and identification in vitro--amitriptyline and verapamil as model compounds.
    Rousu T; Herttuainen J; Tolonen A
    Rapid Commun Mass Spectrom; 2010 Apr; 24(7):939-57. PubMed ID: 20209667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pharmaceutical impurities in formulated dosage forms.
    Pan C; Liu F; Motto M
    J Pharm Sci; 2011 Apr; 100(4):1228-59. PubMed ID: 24081463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.